A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Conditions
Non-Small Cell Lung Cancer · Non-small Cell Lung Cancer Stage II · Non-Small Cell Lung Cancer Stage IIIA · Non-Small Cell Lung Cancer Stage IIIB
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Michigan (Data Collection Only), Ann Arbor, Michigan, United States
Mayo Clinic (Data Collection Only), Rochester, Minnesota, United States
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York, New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York, United States
Centre Hospitalier de l'Université de Montreal (Data Collection Only), Montreal, Quebec, Canada
Study leads
James Isbell, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center